Menu
Recruiting NCT07033975

A Specialized Diet for Multiple Sclerosis

No phase Interventional Multiple Sclerosis

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Flavonoid-enriched Mediterranean Diet.
Who it may be relevant to
Registry conditions: Multiple Sclerosis. Basic parameters: 30 years — 65 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Belgium
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

A Flavonoid-enriched Mediterranean Diet for Multiple Sclerosis

Overview

This study examines the impact of a Mediterranean diet on individuals with multiple sclerosis (MS). MS is a multifactorial disease in which environmental factors, such as nutrition, can influence disease progression. Therefore, this study aims to investigate whether a healthier dietary pattern, specifically a flavonoid-rich Mediterranean diet, can affect disease parameters.

Interventions

  • Other Flavonoid-enriched Mediterranean Diet
    A set of dietary guidelines describing an adjusted Mediterranean diet focusing on the intake of flavonoid-rich products.

Primary outcome measures

  • Microbiota changes [Time frame: Three timepoints, before start of the strict diet (day 14), after the strict diet (day 31), and after the follow-up period of three months (day 122).]

Eligibility criteria

Inclusion criteria

  • Expanded Disability Status Scale (EDSS): 0-6

Exclusion criteria

  • Diagnosed digestive pathology

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
N/A
Model
Sequential
Masking
Open label
Primary purpose
Supportive care

Study locations

Belgium · 1 center
  • Hasselt University — Diepenbeek

Identifiers

NCT: NCT07033975 · B1152023000003

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗